This year, AbbVie has continually been a big spender in the TV ad drug stakes, and it’s showing no signs of slowing down. After launching two new Rinvoq commercials this summer, the Big Pharma is now ...
J&J kicked off the new year with a bang, shelling out more than $78 million to air eight TV ads for Tremfya throughout January, increasing nearly 40% from its December total and again making it far ...
Vicks took the top spot ahead of Rinvoq, Skyrizi and Tremfya, which continue to be the top spenders on national TV pharma ads.
Skyrizi has knocked Dupixent off its pedestal and claimed the top spot for ad impressions by Rx and over-the-counter (OTC) brands in April. The treatment for Crohn’s disease, psoriasis and psoriatic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results